Petra Rüger
Roche (Switzerland)(CH)Roche Pharma AG (Germany)(DE)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research, Alzheimer's disease research and treatments, Metal complexes synthesis and properties, Protein Kinase Regulation and GTPase Signaling
Most-Cited Works
- → In Vitro Glycoengineering of IgG1 and Its Effect on Fc Receptor Binding and ADCC Activity(2015)214 cited
- → Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans(2023)141 cited
- → A Pentacyclic Aurora Kinase Inhibitor (AKI-001) with High in Vivo Potency and Oral Bioavailability(2008)58 cited
- → Mutants of Protein Kinase A that Mimic the ATP-binding Site of Protein Kinase B (AKT)(2003)54 cited
- → Development of a pre-glycoengineered CHO-K1 host cell line for the expression of antibodies with enhanced Fc mediated effector function(2017)29 cited
- → Effect of Fc glycoengineering on ADCC activity.(2015)